Dr. Hella Bolck
Dr. Hella Bolck
ZHAW
School of Engineering
Machine Perception & Cognition Group
Technikumstrasse 71
8400 Winterthur
Work at ZHAW
Position
- Third Space Scientist
- Research- and Project Manager
Focus
- Managing complex projects
- Enabling research in the academic third space
- Using AI for analysis of biological and medical images and data
Professional development teaching
- CAS KI verstehen und anwenden: No-Code Lösungen für die betriebliche Praxis
- WBK Generative KI in Lehre und Weiterbildung
Experience
- Senior Research Scientist
University Hospital Zürich
05 / 2018 - 01 / 2024 - Postdoctoral Scientist
University Hospital Zürich
04 / 2016 - 04 / 2018 - Doctoral Researcher
University of Zürich
09 / 2011 - 04 / 2016
Education and Continuing education
Education
- PhD / Cancer Biology
University of Zürich
09 / 2011 - 04 / 2016 - Master / Biochemistry and Molecular Biology
Friedrich-Schiller University Jena
10 / 2005 - 08 / 2011
Network
ORCID digital identifier
Social media
Projects
- SCRAI – A Think-and-Do-Tank for Responsible Development and Societal Alignment of Artificial Intelligence Systems / Team member / ongoing
- AI for REAL-world NETwork operation / Team member / ongoing
- LINA: Shared Large-scale Infrastructure for the Development and Safe Testing of Autonomous Systems / Deputy project leader / ongoing
Publications
Articles in scientific journal, peer-reviewed
- Bolck, H. et al. (2026) 'LINA's testing infrastructure enables AI to take-off in unmanned aerial vehicles (UAVs)', Frontiers in Robotics and AI, 13(1764248). doi: 10.3389/frobt.2026.1764248.
- Totu, T. et al. (2025) 'NOODAI : a webserver for network-oriented multi-omics data analysis and integration pipeline', Bioinformatics, 41(11), p. btaf553. doi: 10.1093/bioinformatics/btaf553.
- Zajac, N. et al. (2025) 'Comparison of single-cell long-read and short-read transcriptome sequencing via cDNA molecule matching : quality evaluation of the MAS-ISO-seq approach', NAR Genomics and Bioinformatics, 7(3), p. lqaf089. doi: 10.1093/nargab/lqaf089.
- Karakulak, T. et al. (2025) 'Heterogeneous and novel transcript expression in single cells of patient-derived clear cell renal cell carcinoma organoids', Genome Research, 35(4), pp. 698–711. doi: 10.1101/gr.279345.124.
Oral conference contributions and abstracts
Guillaume, M. and Bolck, H. (2025) 'Drohnen-Integration in den zivilen Luftraum', in 21. FFS Security Talk des Forum Sicherheit Schweiz, Bern, Schweiz, 29. April 2025.
Publications before appointment at the ZHAW
- SuperCUT, an unsupervised multimodal image registration with deep learning for biomedical microscopy. Brief. Bioinformatics (2024)
- Genomic alterations and diagnosis of renal cancer. Virchows Archiv (Nov. 2023)
- Ex vivo drug testing of patient‐derived papillary renal cancer cells reveals EGFR and the BCL2 family as therapeutic targets. Eur Urol Focus (Mar. 2023)
- RNAi Screening Uncovers a Synthetic Sick Interaction between CtIP and the BARD1 Tumor Suppressor. Cells (Feb. 2022)
- SF3B1 facilitates HIF1‐signaling and promotes malignancy in pancreatic cancer. Cell Rep (Aug. 2022)
- Liquid Biopsies in Renal Cell Carcinoma—Recent Advances and Promising New Technologies for the Early Detection of Metastatic Disease. Front Oncol (Oct. 2020)
- Cancer Sample Biobanking at the Next Level: Combining Tissue With Living Cell Repositories to Promote Precision Medicine. Front Cell Dev Biol (Oct. 2019)
- Tracing Clonal Dynamics Reveals that Two‐ and Three‐dimensional Patient‐derived Cell Models Capture Tumor Heterogeneity of Clear Cell Renal Cell Carcinoma. Eur Urol Focus (Jun. 2019)
- Scavenger receptor BI promotes cytoplasmic accumulation of lipoproteins in clear‐cell renal cell carcinoma. J Lipid Res (Nov. 2018)
- CtIP‐Mediated Fork Protection Synergizes with BRCA1 to Suppress Genomic Instability upon DNA Replication Stress. Mol Cell (Oct. 2018)
- FANCD2 and CtIP cooperate to repair DNA interstrand crosslinks. Cell Rep (May 2014)
- Targeting DNA double‐strand break signalling and repair: recent advances in cancer therapy. Swiss Med Wkly (Jul. 2013)
- Breakdown of the FLT3‐ITD/STAT5 axis and synergistic apoptosis induction by the histone deacetylase inhibitor panobinostat and FLT3‐ specific inhibitors. Mol Cancer Ther (Sept 2012)